News Archive

It looks like Healthbox is raising a new fund, according to a Form D filing with the U.S. Securities and Exchange Commission. The accelerator is keeping schtum about the Healthbox Opportunity Fund I and declined a request for comment.

Still, its website shows that it is poised to bring its Healthbox Studio accelerators to Orlando, as part of a partnership with Guidewell Innovation Center, and Los Angeles later this year. Healthbox and Guidewell had previous accelerator classes in Miami, Tampa Bay and Jacksonville. Los Angeles is home to a few accelerators, including one between Techstars and Cedars-Sinai.

A University of Maryland startup is among the finalists in Under Armour CEO Kevin Plank’s Cupid’s Cup, a competition offering a $100,000 prize of the winner.

Companies founded on technology licensed from Johns Hopkins University have raised $1 billion since 2010. And 90 percent of those companies are no longer in Maryland.

Christy Wyskiel, who leads Johns Hopkins Technology Ventures, the university’s commercialization arm, hopes to reverse that trend with a new partnership with Village Capital and the Abell Foundation.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys MultiProcessor and BD Totalys SlidePrep instruments.

Innovation takes time – and money, and people and resources. That’s why it’s common for a company to focus on core business activities and not build an innovation lab – a specific building or department dedicated to working on prototypes and fleshing out ideas. 

Remarkable progress has been made over the last century in enhancing public health, driven largely by advances in science, medicine and our understanding of how disease manifests in the human body. As a result, the average life expectancy doubled during the 20th century.

The Institute for Bioscience and Biotechnology Research (IBBR) is interested in proposals to lease a bio-manufacturing facility configured to produce biologicals under cGMP conditions in compliance with FDA requirements for phase I/II clinical trials. The facility is also equipped to perform process development research, preclinical manufacturing for material necessary for IND-enabling toxicology studies, Point of Concept (POC) studies, and process demonstration in advance of GMP manufacturing. The Good Manufacturing Practices (GMP) facility is located on the University of Maryland’s Shady Grove campus at 9600 Gudelsky Drive, Rockville, MD 20850.

It’s a familiar story: a biotechnology company develops a promising product but falls short of sales projections. The company then cuts staff, realigns resources, and turns to startups to fill its depleted pipeline.

While this scenario does play out in pharmaceuticals, it also describes what is happening in agriculture. Big ag companies face pressures to develop agricultural innovations and deliver financial returns. Agbio startups vie to fill big ag product pipelines. But even though motives driving agbio deals are similar to those in pharma, agbio startups can face steeper challenges.

CIITC provides a refundable income tax credit to Qualified Maryland Cybersecurity Companies (QMCCs) that secure investment from investors. The purpose of this new program is to incentivize and attract cybersecurity companies to startup in or move to Maryland; and to attract investment to cybersecurity companies in order to help them grow, create jobs and retain intellectual property in Maryland.

U.S. cities continue to reinvent themselves and demonstrate economic resiliency. While The University of Maryland-College Park (UMCP) has long had a reputation as a high-class research institution, its status has had a limited impact on the community surrounding it. With the evolving partnership between UMCP and the City of College Park, however, College Park is on the verge of becoming a hub for new innovation in the Washington, DC area.